ARTICLE | Clinical News
Zadaxin thymosin alpha I: Began a Phase III trial
March 7, 1994 8:00 AM UTC
SciClone Pharmaceuticals Inc. (SCLN), San Mateo, Calif. Product: Zadaxin thymosin alpha I, an immune stimulatory hormone Indication: Asymptomatic chronic hepatitis B infection Status: Began a Phase I...